Important Disclosure Information. Read Before Proceeding.
Companies
Ironclad
Ironclad
San Francisco, CA
Founded 2014
Business/Productivity Software
Ironclad is a contract lifecycle management platform used by companies to handle every type of contract workflow.
Last Round Valuation
$3.2B
Last Round Share Price
$ XX.XY
Total Funding
$250M
Last Round
Series E

Looking for Augment Collective?

Collective enables investments as low as $10k into private companies. We will prioritize those who have indicated interest on a first-come first-served basis.

Market

Viewing and creating orders is only available to accredited investors or verified shareholders. Log in to create an investment profile.

Funding Rounds

Nothing here
Information contained herein is based on estimates and is subject to update.

News

Ironclad Surpasses $200 Million in Annual Recurring Revenue thumbnail image
03/19/2026
Ironclad Surpasses $200 Million in Annual Recurring Revenue
Ironclad's achievement of over $200 million in annual recurring revenue signals robust demand for its contract lifecycle management solutions, positioning the company for potential strategic partnerships and increased market share in the competitive legal tech landscape.
Ironclad Surpasses $200 Million in Annual Recurring Revenue thumbnail image
02/12/2026
Ironclad Surpasses $200 Million in Annual Recurring Revenue
Ironclad's achievement of over $200 million in annual recurring revenue signals robust demand for its contract lifecycle management solutions, positioning the company for potential strategic partnerships and increased market share in the competitive SaaS landscape.
Ironclad Achieves $150 Million Annual Recurring Revenue, Named Leader in 2025 Gartner Magic Quadrant for Contract Life Cycle Management thumbnail image
11/14/2025
Ironclad Achieves $150 Million Annual Recurring Revenue, Named Leader in 2025 Gartner Magic Quadrant for Contract Life Cycle Management
Ironclad's $150 million annual recurring revenue and leadership position in the Gartner Magic Quadrant underscore its pivotal role in transforming contract management into a strategic advantage, attracting significant investor interest and enhancing its competitive edge.
FAQ
What is Augment?
Does Augment protect my privacy?
Who can use Augment?
Does my company allow sales of shares?
Are orders posted anonymously?
How do I know what price to buy or sell shares?
What size transactions does Augment support?
How can I get notified when there are new interested buyers of my shares?
Which companies are listed on Augment’s marketplace?
What is required to join Augment?
How do Augment fees work?
How do I know if an order is created by a broker or a direct buyer or user?
Is trading on Augment safe and legitimate?
What is the typical process of selling shares?
Augment
© Augment 2023 — All rights reserved. "Augment" refers to Augment Markets, Inc. and its affiliates. Augment Markets, Inc. is a technology company offering software and data services, in addition to financial products and services through its wholly-owned but separately managed subsidiary, Augment Capital, LLC.
Securities products are offered through Augment Capital, LLC, member FINRA/ SIPC. Any information relating to fully diluted shares outstanding or other company related financing or capitalization information are estimates only and should be independently verified by each user in connection with any investment decision. Company data and portfolio calculations are provided by Augment for educational and illustrative purposes only. None of the information displayed on or downloadable from augment.market (the "Website") represents a recommendation, offer, solicitation of an offer, advice, or recommendation to buy, sell, or hold any security. All investing involves risk, including the risk of losing the money you invest, and past performance does not guarantee future performance.
Using the website or the information, tools, features or functionality provided on the website and by Augment Capital, LLC constitutes acceptance of the Augment terms of use, privacy policy, and other important disclosures. Review our Form CRS here.